---
$id: https://graph.org.ai/products/commodity/51142535
$type: Product
source: UNSPSC
code: "51142535"
title: "Phenglutarimide"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Phenglutarimide

**UNSPSC Code**: 51142535
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticholinergic agent with the molecular formula C17H24N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 679RC9H8TG, chemically known as 2,6-piperidinedione, 3-(2-(diethylamino)ethyl)-3-phenyl- but generally known as phenglutarimide, which bears US NIH Compound Identifier 92870. European Medicines Agency schedules Phenglutarimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09762MIG. The term PHENGLUTARIMIDE is an International Non-Proprietary Name. World Health Organization schedules phenglutarimide in its Anatomical Therapeutic Chemical (ATC) Classification. PHENGLUTARIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phenglutarimide under HS 29251995 and SITC 51482. As of Q4 2014, PHENGLUTARIMIDE remains the US FDA Preferred Term for this commodity. Phenglutarimide bears US NLM identifiers UMLS ID C0070561 and NCI Concept Code C90699. SMILES: O=C1NC(=O)CC(C1CCN(CC)CC)C1CCCCC1.

